Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7381)
All Articles published online
|
Publishing Process of This Article
|
Sep 21, 2019 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen QF, Li W, Wu PH, Shen LJ, Huang ZL. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2019; 25(35): 5266-5282 [PMID: 31558872 DOI: 10.3748/wjg.v25.i35.5266] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v25/i35/5266.htm |
| Number | Citing Articles |
| 1 |
Haitao Chen, Yueying Li, Shu-Yuan Xiao, Jianchun Guo. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08012-2
|
| 2 |
Kaifei Zhao, Lin Xu, Feng Li, Jin Ao, Guojun Jiang, Rongshu Shi, Fang Chen, Qing Luo. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature. Bioscience Reports 2020; 40(8) doi: 10.1042/BSR20200894
|
| 3 |
Meiying Long, Zihan Zhou, Xueyan Wei, Qiuling Lin, Moqin Qiu, Yunxiang Zhou, Peiqin Chen, Yanji Jiang, Qiuping Wen, Yingchun Liu, Runwei Li, Xianguo Zhou, Hongping Yu. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1023349
|
| 4 |
Yu Jiang, Lijuan Lin, Huiming Lv, He Zhang, Lili Jiang, Fenfen Ma, Qiuyue Wang, Xue Ma, Shengjin Yu. Immune cell infiltration and immunotherapy in hepatocellular carcinoma. Mathematical Biosciences and Engineering 2022; 19(7): 7178 doi: 10.3934/mbe.2022339
|
| 5 |
Lixing Li, Lu Shen, Jingsong Ma, Qiang Zhou, Mo Li, Hao Wu, Muyun Wei, Di Zhang, Ting Wang, Shengying Qin, Tonghai Xing. Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00451
|
| 6 |
Jianguo Li, Jin Zhou, Shuangshuang Kai, Can Wang, Daijun Wang, Jiying Jiang. Functional and Clinical Characterization of Tumor-Infiltrating T Cell Subpopulations in Hepatocellular Carcinoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.586415
|
| 7 |
Bo Hu, Xiao-Bo Yang, Xin-Ting Sang. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients. International Immunopharmacology 2021; 90: 107164 doi: 10.1016/j.intimp.2020.107164
|
| 8 |
Jun Liu, Zheng Chen, Wenli Li, Zhixiong Liu. Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/6676537
|
| 9 |
Banglun Pan, Lin Liu, Wei Li. A prognostic risk model based on immune‐related genes predicts overall survival of patients with hepatocellular carcinoma. Health Science Reports 2020; 3(4) doi: 10.1002/hsr2.202
|
| 10 |
Rongfu Huang, Zheng Chen, Wenli Li, Chunmei Fan, Jun Liu. Immune system‑associated genes increase malignant progression and can be used to predict clinical outcome in patients with hepatocellular carcinoma. International Journal of Oncology 2020; doi: 10.3892/ijo.2020.4998
|
| 11 |
Yue Ding, Yilin Yan, Yihui Dong, Jingyuan Xu, Wei Su, Weijun Shi, Qi Zou, Xiaoping Yang. NLRP3 promotes immune escape by regulating immune checkpoints: A pan-cancer analysis. International Immunopharmacology 2022; 104: 108512 doi: 10.1016/j.intimp.2021.108512
|
| 12 |
Leteng Yang, Jie Wei, Xiaoya Ma, Rui Cheng, Huan Zhang, Tianbo Jin. Pan-Cancer Analysis of the Prognostic and Immunological Role of <i>SMG5</i>: A Biomarker for Cancers. Oncology 2024; 102(2): 168 doi: 10.1159/000533421
|
| 13 |
Jian-Nan Liu, Xiang-Shuo Kong, Tao Huang, Rui Wang, Wang Li, Qi-Feng Chen. Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.02048
|
| 14 |
Jian‐Nan Liu, Xiang‐Shuo Kong, Ping Sun, Rui Wang, Wang Li, Qi‐Feng Chen. An integrated pan‐cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity. Journal of Cellular and Molecular Medicine 2021; 25(4): 2082 doi: 10.1111/jcmm.16147
|
| 15 |
Yutao Yuan, Fangnian Yang, Yuanyuan Wang, Yusong Guo. Factors associated with liver cancer prognosis after hepatectomy. Medicine 2021; 100(42): e27378 doi: 10.1097/MD.0000000000027378
|
| 16 |
Yichun Wang, Chengjian Ji, Jinhui Liu, Yamin Wang, Ninghong Song, Pu Cao. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors. International Immunopharmacology 2020; 86: 106710 doi: 10.1016/j.intimp.2020.106710
|